Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Burn, Burn Wounds - Partial Thickness (2nd Degree)

In brief

This multicentre, randomised, double-blind, dose-finding, active- and placebo-controlled Phase II clinical trial will evaluate the safety, efficacy, pharmacokinetic profile, and immunogenicity of KJ101 for the debridement of deep second-degree burns. The trial will provide supporting evidence for subsequent Phase III trials.

Key facts

Study ID
NCT07025408
Run by
Shanghai Bao Pharmaceuticals Co., Ltd.
People needed
144
Starts
2025-06-16
Expected to finish
2026-08-29
Last updated by the study team
2025-06-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.